These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Thyrotropin-releasing hormone: biosynthesis by rat hypothalamic fragments in vitro. Mitnick M; Reichlin S Science; 1971 Jun; 172(3989):1241-3. PubMed ID: 4995924 [TBL] [Abstract][Full Text] [Related]
23. Development of a continuous, fluorometric coupled enzyme assay for thyrotropin-releasing hormone-degrading ectoenzyme. Kelly JA; Slator GR; Tipton KF; Williams CH; Bauer K Anal Biochem; 1999 Oct; 274(2):195-202. PubMed ID: 10527516 [TBL] [Abstract][Full Text] [Related]
24. Partial purification and some properties of pyroglutamyl peptidase from Enterococcus faecalis. Mineyama R; Saito K Microbios; 1998; 94(377):47-62. PubMed ID: 9785485 [TBL] [Abstract][Full Text] [Related]
25. Immunological, physical, and chemical evidence for the identity of brain and kidney post-proline cleaving-enzyme. Hersh LB J Neurochem; 1981 Jul; 37(1):172-8. PubMed ID: 7019392 [TBL] [Abstract][Full Text] [Related]
26. TRH analogue with C-terminal thioamide group: rapid degradation by plasma and its biological effects. Angyal R; Strbák V; Alexandrová M; Kruszyński M Endocrinol Exp; 1985 Dec; 19(4):213-9. PubMed ID: 3002750 [TBL] [Abstract][Full Text] [Related]
27. Enzymatic degradation of thyrotropin releasing hormone by pancreatic homogenates. Failure to detect His-Pro-diketopiperazine as TRH metabolite. Aratan-Spire S; Wolf B; Czernichow P Neuroendocrinology; 1986; 42(5):399-406. PubMed ID: 3084986 [TBL] [Abstract][Full Text] [Related]
28. High-pressure liquid chromatographic assay for the determination of thyrotropin-releasing hormone and its common metabolites in a physiological salt solution circulated through the isolated perfused rat lung. Visich JE; Byron PR J Pharm Biomed Anal; 1996 Oct; 15(1):105-10. PubMed ID: 8895081 [TBL] [Abstract][Full Text] [Related]
29. Ontogeny of prolyl endopeptidase and pyroglutamyl peptidase I in rat tissues. Agirregoitia N; Casis L; Gil J; Ruiz F; Irazusta J Regul Pept; 2007 Mar; 139(1-3):52-8. PubMed ID: 17123646 [TBL] [Abstract][Full Text] [Related]
30. L-6-ketopiperidine-2-carbonyl-L-leucyl-L-proline amide as a novel thyrotropin releasing hormone analogue with improving effects on impaired central nervous systems functions. Oka M; Ochi Y; Furukawa K; Ito T; Miura Y; Karasawa T; Kadokawa T Arzneimittelforschung; 1989 Mar; 39(3):297-303. PubMed ID: 2547386 [TBL] [Abstract][Full Text] [Related]
32. Biological activity of TRH thionalogue and its diastereoisomers. Alexandrová M; Strbák V; Herman ZS; Stachura Z; Kruszyński M Endocrinol Exp; 1987 Mar; 21(1):43-9. PubMed ID: 3106009 [TBL] [Abstract][Full Text] [Related]
33. Purification and properties of a 4-methylene-L-glutamine amidohydrolase from peanut leaves. Powell GK; Dekker EE J Biol Chem; 1983 Jul; 258(14):8677-83. PubMed ID: 6863306 [TBL] [Abstract][Full Text] [Related]
34. Characterization of "thyroliberin-deamidating enzyme" as a post-proline-cleaving enzyme. Partial purification and enzyme-chemical analysis of the enzyme from anterior pituitary tissue. Knisatschek H; Bauer K J Biol Chem; 1979 Nov; 254(21):10936-43. PubMed ID: 115864 [TBL] [Abstract][Full Text] [Related]
35. Pyroglutamyl peptidase II inhibition enhances the analeptic effect of thyrotropin-releasing hormone in the rat medial septum. Lazcano I; Uribe RM; Martínez-Chávez E; Vargas MA; Matziari M; Joseph-Bravo P; Charli JL J Pharmacol Exp Ther; 2012 Jul; 342(1):222-31. PubMed ID: 22532627 [TBL] [Abstract][Full Text] [Related]
36. Pyroglutamyl-phenylalanyl-proline amide attenuates thyrotropin-releasing hormone-stimulated insulin secretion in perifused rat islets and insulin-secreting clonal beta-cell lines. Kulkarni RN; Wang ZL; Akinsanya KO; Bennet WM; Wang RM; Smith DM; Ghatei MA; Byfield PG; Bloom SR Endocrinology; 1995 Nov; 136(11):5155-64. PubMed ID: 7588254 [TBL] [Abstract][Full Text] [Related]
37. Discovery of a dual action first-in-class peptide that mimics and enhances CNS-mediated actions of thyrotropin-releasing hormone. Scalabrino GA; Hogan N; O'Boyle KM; Slator GR; Gregg DJ; Fitchett CM; Draper SM; Bennett GW; Hinkle PM; Bauer K; Williams CH; Tipton KF; Kelly JA Neuropharmacology; 2007 Jun; 52(7):1472-81. PubMed ID: 17418282 [TBL] [Abstract][Full Text] [Related]
38. The subcellular and organ distribution and natural form of histidyl-proline diketopiperazine in rat brain determined by a specific radioimmunoassay. Yanagisawa T; Prasad C; Peterkofsky A J Biol Chem; 1980 Nov; 255(21):10290-4. PubMed ID: 7430126 [TBL] [Abstract][Full Text] [Related]
39. Evidence for regulation of a thyrotropin-releasing hormone degradation pathway in GH3 cells. Friedman TC; Davies TF; Wilk S Endocrinology; 1986 Feb; 118(2):562-6. PubMed ID: 3080309 [TBL] [Abstract][Full Text] [Related]
40. The thyrotropin-releasing hormone-degrading ectoenzyme: the third element of the thyrotropin-releasing hormone-signaling system. Heuer H; Schäfer MK; Bauer K Thyroid; 1998 Oct; 8(10):915-20. PubMed ID: 9827659 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]